Intrarenal Bacillus Calmette-Guerin perfusion therapy was effective for carcinoma in situ of the upper urinary tract after ileal conduit replacement: A case report - Abstract

A 63-year-old man who had undergone radical cystectomy and ileal conduit formation for invasive bladder cancer 3 years before presented with continuous positive urinary cytology in the ileal conduit.

His diagnosis was carcinoma in situ (CIS) of the left upper urinary tract. He was treated with Bacillus Calmette-Guérin (BCG) perfusion therapy using a single-J ureteric stent. BCG (80 mg) in 100 ml saline was instilled in a one-hour period weekly for 6 weeks. Usage of another catheter was effective for continuing the therapy. Urinary cytology in the left upper urinary tract and the ileal conduit became negative after the therapy. There was no evidence of recurrence or metastasis of urothelial carcinoma 6 months after the therapy.

Written by:
Hayashi T, Yamanaka Y, Kinjo T, Katayama K, Kamoto A, Mori N, Yoshioka T.   Are you the author?
The Department of Urology, Sumitomo Hospital.

Reference: Hinyokika Kiyo. 2014 Apr;60(4):175-8.


PubMed Abstract
PMID: 24882229

Article in Japanese.

UroToday.com Upper Tract Tumors Section